Mark Malamood, MD

Clinical Interests

• Barrett's Esophagus
• GERD
• Esophageal cancer
• Esophageal dysmotility
• Colorectal cancer
• Large colon polyp removal
• Management of GI bleeding
• Dysphagia (difficulty swallowing)

Research Interests

• Treatment of Barrett's Esophagus
• Management of achalasia
• New therapies for esophageal dysmotility
• Endoscopic treatment of GERD

Educational Background

• Fellowship, Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA
• Residency, Internal Medicine, Temple University Hospital, Philadelphia, PA
• MD, Albany Medical College, Albany, NY

Certifications

• Internal Medicine
• Gastroenterology
• Hepatology

Memberships

• American College of Gastroenterology
• American Gastrointestinal Association
• American Society for Gastrointestinal Endoscopy

Digital Bibliography

1. Malamood M, Roberts A, Kataria R, et al. Mirtazapine for symptom control in refractory gastroparesis. Drug Design, Development, and Therapy. 2017 March; 11: 1035-1041.

2. Hongo T, Zheng M, Malamood M, et al. A case of Amanita Phalloides poisoning that Avoided Liver Transplantation. The Medicine Forum. 2017 Dec;18:12-14.

3. Mark Malamood MD; Gregory Bernstein MD; Zubair Malik MD; Malini Mathur MD. Massive Esophageal Variceal Bleeding: A Rare Complication of Sickle Cell Anemia. ACG Case Report J. 2016 Jan 20;3(2):92-4.

4. Mark Malamood MD, Henry Parkman MD, Ron Schey MD. Advances in The Treatment of Gastroparesis. Expert Opinion on Pharmacotherapy 2015 Sept; 16 (13): 1997-2008

5. Mark Malamood MD; Eric Nellis MD; Frank Friedenberg MD, Adam Ehrlic MD. Vancomycin Enemas as Adjunctive Therapy for Clostridium difficile Infection. Journal of Clinical Medicine Research 2015 June; 7 (6): 422-27.

6. Mark Malamood MD; Ron Schey MD, FACG. Diminished Quality of Life in Non-Cardiac Chest Pain: As Much A Cause As It Is An Effect. Rev Gastroenterol Mex 2015 April-June; 80 (2): 119-120.